GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,610.50p
   
  • Change Today:
    -33.00p
  • 52 Week High: 1,711.20
  • 52 Week Low: 1,316.00
  • Currency: UK Pounds
  • Shares Issued: 4,114.88m
  • Volume: 7,541,741
  • Market Cap: £66,270m
  • RiskGrade: 129

GSK Overview

We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 2.6% 0.0%
Div Cover 3.7 2.6
Op Mrgn 22.2% 27.5%
ROCE 67.1%  
Latest F'cast
P/E 10.4 10.4
PEG 0.9 5.7
Pr/Revenue 2.2 2.1
Pr/Book 5.2  
Latest F'cast
Revenue 3.4% 4.2%
PBT 7.7% 43.5%
EPS 11.0% 1.0%
DPS -4.5% 45.2%

GSK Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 33,754.00 6,221.00 123.90p 17.9 4.5 +4% 80.00p 3.6%
31-Dec-20 34,099.00 6,968.00 115.90p 14.5 n/a -6% 80.00p 4.8%
31-Dec-21 24,696.00 3,599.00 90.56p 22.2 n/a -22% 80.00p 4.0%
31-Dec-22 29,324.00 5,628.00 139.70p 10.3 0.2 +54% 44.00p 3.1%
31-Dec-23 30,328.00 6,064.00 155.10p 9.4 0.9 +11% 42.00p 2.9%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GSK Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 31,607.48 8,699.70 156.71p 10.3 9.9 +1% 61.00p 0.0%
31-Dec-25 33,531.44 9,662.45 175.23p 9.2 0.8 +12% 65.55p 0.0%
31-Dec-26 35,171.76 10,634.73 191.66p 8.4 0.9 +9% 71.56p 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

GSK Company Announcements

Amendment - Director/PDMR Shareholding 16-Apr-2024 14:11 RNS
FDA accepts GSK meningitis vaccine candidate file 16-Apr-2024 07:00 RNS
Director/PDMR Shareholding 15-Apr-2024 15:30 RNS

GSK ShareCast News

GSK meningococcal vaccine accepted by US FDA for... 16-Apr-2024 ShareCast
GSK unveils promising results from endometrial c... 18-Mar-2024 ShareCast
GSK reports more encouraging trial results for B... 07-Mar-2024 ShareCast

GSK Top Newspaper Links

GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent
GSK to cut hundreds of US jobs 01-Dec-2014 Telegraph

Latest GSK Director Deals

Traded Action Notifier PriceAmountValue
12-Apr-24 Buy Dividends Vishal Sikka 3,289.66p 43 £1,414.56
12-Apr-24 Buy Dividends Jesse Goodman 3,289.66p 9 £296.07
12-Apr-24 Buy Dividends Harry (Hal) C. Dietz 3,289.66p 9 £296.07

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GSK Market Data

Currency UK Pounds
Share Price 1,610.50p
Change Today -33.00p
% Change -2.01 %
52 Week High 1,711.20
52 Week Low 1,316.00
Volume 7,541,741
Shares Issued 4,114.88m
Market Cap £66,270m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
78.47% below the market average78.47% below the market average78.47% below the market average78.47% below the market average78.47% below the market average
39.62% below the sector average39.62% below the sector average39.62% below the sector average39.62% below the sector average39.62% below the sector average
Price Trend
25.09% above the market average25.09% above the market average25.09% above the market average25.09% above the market average25.09% above the market average
68.42% above the sector average68.42% above the sector average68.42% above the sector average68.42% above the sector average68.42% above the sector average
Income
44.36% above the market average44.36% above the market average44.36% above the market average44.36% above the market average44.36% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
26.19% below the market average26.19% below the market average26.19% below the market average26.19% below the market average26.19% below the market average
40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average

What The Brokers Say

Strong Buy 8
Buy 5
Neutral 9
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 22-Feb-24 16-Nov-23
Paid 11-Apr-24 11-Jan-24
Amount 16.00p 14.00p

Trades for 16-Apr-2024

Time Volume / Share Price
16:49 347,529 @ 1,609.70p
16:35 1,142 @ 1,610.50p
16:35 143 @ 1,610.50p
16:35 2,437 @ 1,610.50p
16:35 2,580 @ 1,610.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page